Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Angelo's story about taking part in our kidney cancer trial
Sign up now to join our Km's for Cancer Research Challenge in October
Submit your trial idea by 6 October for our 2026 Concept Development Workshop
Abstract submissions for TROG 2027 ASM close 9 October: Submit your abstract now.
TROG ASM Attendance Grants: Applications now open

EORTC/TROG 01.03 – Glioblastoma/Temozolomide – 26981/22981

Completed

Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme. A Randomized Phase III Study

Primary Sponsor

EORTC

Collaborating Groups

TROG Cancer Research

Prev Post

TROG 01.04 – Rectal (Phase III)

Next Post

EORTC 22996-24002/TROG 01.01 – EPO Head & Neck

Related Post

26 September, 2026

Trial finds radiation therapy halves risk of brain tumour recurrence after surgery

LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team